๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers Clinical trials Beijing
Clinical trial register · China

Clinical Trials in Beijing, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Nanjing 30 Beijing 9 Guangzhou 6 Chengdu 5 Shanghai 4
Narrow the registerReset
Recruitment status
Phase
Site location
Nanjing30 Beijing9 Guangzhou6 Chengdu5 Shanghai4
All 15 locations
Target enrolment
to

Trials with a site in Beijing

9 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
AI-assisted Subtyping-directed Precision Treatment in Acute Aortic Dissection
NCT07382375Aortic Aneurysm and Dissection
Nanjing Medical University
Not applicable
300
Beijing, Changzhou, Chengdu, Fuzhou, Guangzhou, Nanchang, Nanjing, Shanghai
2027-12-31
By invitation
Protective Effect of Ulinastatin and Thymosin ฮฑ1 Against Negative Immune Dysregulation and Organ Dysfunction After Acute Aortic Dissection Surgery (PANDA XI)
NCT06966687Aortic Dissection, Aortic Dissection Aneurysm
Nanjing Medical University
Not applicable
200
Beijing, Guangzhou, Shanghai, Chengdu
2025-04-01
Not yet open
Protective Effect of Angong Niuhuang Against Negative Inflammatory Response and Neurologic Dysfunction After Cardiovascular Surgery
NCT06723366Cardio-pulmonary Bypass, Cardiovascular Surgery, Cerebral Protection, Brain Injury
Nanjing Medical University
Not applicable
120
Beijing, Nanjing
2025-01-01
By invitation
Protective Effect of Probacine Against Negative Gut Metabolism and Organ Dysfunction After Cardiovascular Surgery (PANDA IV)
NCT04444362Cardiovascular Disease, Cardiopulmonary Bypass
Nanjing Medical University
Not applicable
500
Beijing, Guangzhou, Nanjing, Chengdu, Shanghai
2025-01-01
Not yet open
Protective Effect of PCSK9 Inhibitor Against Negative Inflammatory Response and Organ Dysfunction After Coronary Artery Bypass Grafting (PANDA VIII)
NCT06730802Myocardial Ischaemic Syndrome, Coronary Heart Disease
Nanjing Medical University
Not applicable
400
Beijing, Nanjing
2025-01-01
Recruiting
Protective Effect of Sivelestat Against Negative Pulmonary Function and Organ Dysfunction After Cardiovascular Surgery (PANDA VI)
NCT06195267Aortic Dissection, Systemic Inflammatory Response Syndrome, Cardiovascular Diseases (CVD)
Nanjing Medical University
Not applicable
500
Beijing, Nanjing
2024-07-01
Recruiting
Protective Effect of CoQ10 Against Negative Inflammatory Response and Organ Dysfunction in Cardiovascular Surgery (PANDA V)
NCT04444349Cardiovascular Disease
Nanjing Medical University
Not applicable
500
Beijing, Guangzhou, Nanjing, Chengdu
2021-02-01
Recruiting
Protective Effect of Statin Against Negative Cardiovascular Remodeling and Organ Dysfunction After Acute Aortic Syndrome Surgery (PANDA III)
NCT04699279Acute Aortic Syndrome, Aortopathy
Nanjing Medical University
Not applicable
300
Guangzhou, Nanjing, Qingdao, Chengdu, Beijing
2021-01-01
Recruiting
Additive Anti-inflammatory Action for Aortopathy & Arteriopathy
NCT04398992Acute Aortic Syndrome
Nanjing Medical University
Observational
10,000
Beijing, Chongqing, Guangzhou, Nanning, Xingyi, Harbin, Changzhou, Suqian
2016-01-01
Rows per page Showing 1–9 of 9
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/beijing

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 9 of those studies with a site in Beijing that also match the filters currently applied.

How many clinical trials are recruiting in Beijing?

4 of the 9 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 3 have not yet opened recruitment, 0 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Beijing), 9 studies
PhaseStudiesRecruitingShare
Not applicable8388.9%
Observational1111.1%

Most active sponsors

Lead sponsors with the most studies (Beijing)
Lead sponsorStudiesRecruiting
Nanjing Medical University94
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.